Lonza Group


A short-term margin squeeze

02/06/22 -"We have revised downwards our profitability expectations due to the significant price increases for consumables and single-use products. Compounded by the higher costs for energy and freight. All in ..."

Pages
52
Language
English
Published on
02/06/22
You may also be interested by these reports :
17/08/22
Zantac and Biden seem to have taken the wind from even the strongest pharma groups’ sails with the sector being the worst performer last week and ...

16/08/22
To factor in the negative investor sentiment regarding the potential adverse implications of the Zantac trial in the US (expected to start by end-Aug ...

16/08/22
2Q/1H22: Strong cash position and pipeline prioritization

16/08/22
Given the negative investor sentiment regarding the potential negative implications associated with the start of the trial (by end-Aug 2022) for ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO